Amarin Corporation

Amarin Corporation Book Value per Share

The Book Value per Share of Amarin Corporation (AMRN) as of Nov 19, 2026 is 22.13 USD. In the previous year, Book Value per Share was 23.43 USD — a change of -5.53% (lower).

Book Value per Share

22.13USD

YoY

-5.53%

Last updated:

Book Value per Share of Amarin Corporation is 2025 22.13 USD. Book Value per Share of Amarin Corporation was 2024 23.43 USD. It decreases by -5.53% lower compared to the previous year.

The Amarin Corporation Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2018
7.34 USD
Jan 1, 2019
29.32 USD
Jan 1, 2020
30.24 USD
Jan 1, 2021
32.15 USD
Jan 1, 2022
28.69 USD
Jan 1, 2023
26.61 USD
Jan 1, 2024
23.43 USD
Jan 1, 2025
22.13 USD
The Amarin Corporation Book Value per Share history
YEARBook Value per ShareYoY
22.13USD-5.53%
23.43USD-11.94%
26.61USD-7.26%
28.69USD-10.76%
32.15USD+6.31%
30.24USD+3.16%
29.32USD+299.31%
7.34USD-333.99%
-3.14USD+618.70%
-0.44USD-92.99%
-6.23USD+46.06%
-4.26USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Amarin Corporation Stock analysis

What does Amarin Corporation do? Amarin Corporation PLC generates revenue primarily through the sale of Vascepa (icosapent ethyl) capsules, approved by the FDA for reducing triglyceride levels in patients with severe hypertriglyceridemia. The company sells Vascepa to wholesalers, regional wholesalers, and specialty pharmacy providers, collectively referred to as distributors, who then resell the product to retail pharmacies for patient and healthcare provider use. The MARINE indication, derived from the MARINE study, is the key approved use driving sales in the cardiovascular health segment. Amarin's commercial strategy centers on the Vascepa segment, focusing on the development and commercialization of this therapeutic. The firm's lead product, Vascepa, is positioned as an adjunct to diet for treating severe hypertriglyceridemia, targeting healthcare providers and patients through a distribution network of wholesalers and specialty pharmacies. This model ensures Vascepa reaches retail pharmacies where it is dispensed to end users. Amarin Corporation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Amarin Corporation stock

Book Value per Share of Amarin Corporation is 22.13 USD in 2025.

Book Value per Share of Amarin Corporation changed from 23.43 USD to 22.13 USD, representing a -5.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Amarin Corporation since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Amarin Corporation

All Key Metrics — Amarin Corporation